O'Shaughnessy Asset Management’s Vaxcyte PCVX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Buy	+4,371	New	+$237K	﹤0.01%	1920
2025 Q1	–	Sell	-4,884	Closed	-$400K	–	2370
2024 Q4	$400K	Sell	4,884 -2,062	-30%	-$205K	﹤0.01%	1379
2024 Q3	$786K	Buy	6,946 +2,681	+63%	+$242K	0.01%	1013
2024 Q2	$322K	Sell	4,265 -438	-9%	-$29.8K	﹤0.01%	1328
2024 Q1	$321K	Buy	+4,703	New	+$326K	﹤0.01%	1289
2021 Q3	–	Sell	-426	Closed	-$10K	–	2828
2021 Q2	$10K	Buy	+426	New	+$8.72K	﹤0.01%	1999

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

O'Shaughnessy Asset Management's PCVX Position: Q2 2026 in Review

O'Shaughnessy Asset Management opened a new position in Vaxcyte (PCVX) in Q2 2026: 4,371 shares worth $254K. The stake represents ﹤0.01% of the portfolio and ranks #1920 among its holdings. This is a return to the name: O'Shaughnessy Asset Management previously reported a position in PCVX as recently as Q4 2024.

O'Shaughnessy Asset Management first reported a position in PCVX in Q2 2021 and has held it in 6 quarters since. The position peaked at $786K in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

O'Shaughnessy Asset Management held 4,371 shares of Vaxcyte worth $254K as of Q2 2026.
Vaxcyte was a new O'Shaughnessy Asset Management position in Q2 2026.
Vaxcyte made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1920 holding.
O'Shaughnessy Asset Management first reported a position in Vaxcyte in Q2 2021 and has held it in 6 quarters since.
O'Shaughnessy Asset Management's Vaxcyte position peaked at $786K in Q3 2024.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.